Allogene Therapeutics Reports Third Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports Third Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 2.05 -0.03 (1.44%)
Previous Close $2.08    52 Week High
Open $2.07    52 Week Low
Day High $2.09    P/E N/A 
Day Low $2.03    EPS
Volume 1,006,211